Botanical label strengths are "very confusing" and "sometimes...misleading" -- FDA chemist.
This article was originally published in The Tan Sheet
Executive Summary
BOTANICAL LABEL STRENGTHS CAN BE "VERY CONFUSING" AND "MISLEADING" to consumers, FDA Center for Drug Evaluation and Research Division of Antiviral Drug Products Supervisory Chemist Chi-Wan Chen, PhD, said at an April 9-10 botanicals workshop sponsored by the Drug Information Association in Washington, D.C. Chen is a member of a CDER working group that is developing a guidance document for industry on how to file an application to either test or market a botanical drug. The group consists of chemists, pharmacologists and clinicians.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning